Trump said you could learn something from this man

Early Warning: A Deep Crack Is Forming In The US Economy Stocks are booming thanks to Trump’s landslide victory. Yet one former Trump advisor says the picture is less rosy than it seems. “I’ve found a deep crack forming in the foundations of the US economy,” he says. “And before too long, it could tear our country apart.” It’s critical you learn more today, BEFORE it impacts your money and your retirement.

Donald Milder Biography and Net Worth

Director of Inari Medical

Donald Milder
Chairman of the Board
Donald Milder has served as a member of our board of directors since September 2011 and as its Chair since December 2019. In 1999, Mr. Milder co-founded Versant Venture Management, LLC, or Versant, where he has been a Managing Director since its inception. Versant is a venture capital firm that invests in medical devices, biotechnology, life science, pharmaceuticals and healthcare sectors. Previously, Mr. Milder was a Managing Director with CPVP Management LP from August 1989 to November 1999, where he was responsible for their healthcare investments. Prior to this, Mr. Milder was the Chief Executive Officer of Infusion Systems Corporation from 1984 to 1989. He currently serves as a board member for Eclipse Regenesis, Inc., Okami, NeoSeq Ltd. and Ceres Foundation. Mr. Milder received a B.A. from Union College and an M.B.A. from Harvard Business School.

What is Donald B. Milder's net worth?: The estimated net worth of Donald B. Milder is at least $148.45 million as of November 7th, 2023. Mr. Milder owns 3,029,614 shares of Inari Medical stock worth more than $148,451,086 as of November 21st. This net worth evaluation does not reflect any other assets that Mr. Milder may own. Learn More about Donald B. Milder's net worth.
How do I contact Donald B. Milder?: The corporate mailing address for Mr. Milder and other Inari Medical executives is 9 Parker Suite 100, Irvine CA, 92618. Inari Medical can also be reached via phone at 877-923-4747 and via email at [email protected]. Learn More on Donald B. Milder's contact information.
Has Donald B. Milder been buying or selling shares of Inari Medical?: Donald B. Milder has not been actively trading shares of Inari Medical in the last ninety days. Most recently, on Tuesday, November 7th, Donald B. Milder bought 54,000 shares of Inari Medical stock. The stock was acquired at an average cost of $53.44 per share, with a total value of $2,885,760.00. Following the completion of the transaction, the director now directly owns 3,029,614 shares of the company's stock, valued at $161,902,572.16. Learn More on Donald B. Milder's trading history.
Who are Inari Medical's active insiders?: Inari Medical's insider roster includes Rebecca Chambers (Director), Mitch Hill (CFO), William Hoffman (CEO), Andrew Hykes (CEO, President & Director), Donald Milder (Director), Kirk Nielsen (Director), and Thomas Tu (Insider). Learn More on Inari Medical's active insiders.
Are insiders buying or selling shares of Inari Medical?: In the last year, insiders at the sold shares 26 times. They sold a total of 531,244 shares worth more than $26,328,373.16. The most recent insider tranaction occured on November, 18th when Director William Hoffman sold 60,000 shares worth more than $3,069,600.00. Insiders at Inari Medical own 10.6% of the company. Learn More about insider trades at Inari Medical.
Information on this page was last updated on 11/18/2024.

Donald B. Milder Insider Trading History at Inari Medical

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
11/7/2023	Buy	54,000	$53.44	$2,885,760.00	3,029,614
11/15/2022	Sell	7,000	$80.13	$560,910.00	3,185,614
10/18/2022	Sell	7,000	$80.07	$560,490.00	3,192,614
9/15/2022	Sell	7,000	$80.25	$561,750.00	3,199,614
8/15/2022	Sell	7,000	$80.78	$565,460.00	3,206,614
8/2/2022	Sell	21,000	$80.44	$1,689,240.00	3,423,614
4/18/2022	Sell	7,000	$86.89	$608,230.00	3,654,614
3/16/2022	Sell	7,000	$80.18	$561,260.00
2/23/2022	Sell	100	$80.00	$8,000.00
2/15/2022	Sell	335	$80.01	$26,803.35
2/9/2022	Sell	400	$80.06	$32,024.00
12/10/2021	Sell	7,000	$79.00	$553,000.00
10/8/2021	Sell	7,000	$79.33	$555,310.00
9/10/2021	Sell	7,000	$81.02	$567,140.00	244,203
8/10/2021	Sell	7,000	$90.64	$634,480.00	244,203
7/9/2021	Sell	7,000	$92.72	$649,040.00	244,203
5/10/2021	Sell	7,000	$90.43	$633,010.00	239,841
4/9/2021	Sell	7,000	$112.19	$785,330.00	239,841
3/10/2021	Sell	7,000	$116.64	$816,480.00	239,841
1/11/2021	Sell	7,000	$84.59	$592,130.00	239,841
12/10/2020	Sell	7,000	$68.09	$476,630.00	239,841

Donald B. Milder Buying and Selling Activity at Inari Medical

Inari Medical Company Overview

Inari Medical, Inc. builds minimally invasive, novel, and catheter-based mechanical thrombectomy devices and accessories for the specific disease states in the United States. The company provides ClotTriever system, which is designed to core, capture, and remove large clots from large vessels for treatment of deep vein thrombosis and peripheral thrombus; FlowTriever system, a large bore catheter-based aspiration and mechanical thrombectomy system to remove large clots from large vessels in the peripheral vasculature for treating pulmonary embolism and other complex venous thromboembolism cases; InThrill system to treat small vessel thrombosis; and LimFlow system for patients who have chronic limb-threatening ischemia with no suitable endovascular or surgical revascularization options and risk of major amputation. It serves interventional radiologists, interventional cardiologists, and vascular surgeons. The company was formerly known as Inceptus Newco1 Inc. and changed its name to Inari Medical, Inc. in September 2013. Inari Medical, Inc. was incorporated in 2011 and is headquartered in Irvine, California.

Today's Range

Now: $49.00

$47.97

$50.96

50 Day Range

MA: $45.52

$40.62

$53.35

2 Week Range

Now: $49.00

$36.73

$67.13

Volume

641,559 shs

Average Volume

929,354 shs

Market Capitalization

$2.87 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.96

Trump said you could learn something from this man

From Wide Moat Research | Ad

Here’s everything you need to know.